“glomerulonephritis.”的搜索结果，显示 351-360 项，共有 8934 项

1. 泌尿科- 临床试验- 妙佑医疗国际

   Rochester, Minn. Levels of bladder cancer-derived extracellular vesicles become undetectable after radical cystectomy in patients with localized bladder cancer.

2. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute ...

3. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to learn about how platelets adhere to the blood von Willebrand factor and how known clinical mutations that ...

4. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to examine the microbiome and immune function in patients with active lymphoma, and in patients with a history of ...

5. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute ...

6. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to determine if the drug combination of acalabrutinib, durvalumab, and venetoclax will work to treat Richter's ...

7. 动脉瘤- 医生与科室- 妙佑医疗国际

   血管壁上的隆起或鼓胀可能不会引起并发症。了解不同类型的动脉瘤。

8. 肾动脉狭窄- 医生与科室- 妙佑医疗国际

   ... glomerulonephritis, Renal tubular acidosis, Kidney injury, Medullary sponge kidney, Single kidney, Shrinking kidney, Multicystic kidney dysplasia, Horseshoe ...

9. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to determine if the drug combination of acalabrutinib, durvalumab, and venetoclax will work to treat Richter's ...

10. 血液科- 临床试验- 妙佑医疗国际

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...